Education and Training

Radiation Therapy Residency

Medical Students

Medical Physics Residency

Rapid Turnaround, Home-based Saliva Testing for COVID-19

The aim of the study is to demonstrate the feasibility and validity of a saliva based home surveillance monitoring test for SARS-CoV-2 infection.

Participants will be asked to carry out as many tests as are included in the bag they are provided, on a daily basis until they are used up.

Stanford is currently not accepting patients for this trial.

Stanford Investigator(s):

Intervention(s):

  • device: Saliva test kit

Eligibility


Inclusion Criteria:

   - Hospitalized patients

      - Hospitalized at Stanford Health Care for COVID-related complications and tested
      positive for SARS-CoV-2 with a PCR-based test

      - Able to understand and consent to study and with a clinical trajectory likely to
      be consistent with multi-day participation

   - High-risk/positive population

      - Seeking testing for suspected COVID or a participant in a study of COVID-positive
      outpatients

      - Own an internet-enabled phone or device capable of loading web pages, receiving
      text messages, and taking/uploading photos.

      - Willing to participate in the study for 6 months

   - Low-risk population

      - Own an internet-enabled phone or device capable of loading web pages, receiving
      text messages, and taking/uploading photos.

      - Willing to participate in the study for 6 months

Exclusion Criteria:

   - All participants:

      - Participants with salivary gland dysfunction (including patients with Sjogren's
      disease or those with xerostomia associated with lupus or rheumatoid arthritis)

      - Participants will not be eligible if they identify any reason they are unable to
      participate in the study

   - High-risk/positive population

      - Participants who have color blindness

      - Participants unable to operate the SnapDx device

   - Low-risk population

      - Participants with prior confirmed SARS-CoV-2 infection

      - Participants who have color blindness

      - Participants unable to operate the SnapDx device

Ages Eligible for Study

2 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Study Team
650-374-0085
Not Recruiting